Biomedical Nanotechnology for Cancer

Amy Pope-Harman; Mark Ming Cheng Cheng; Fredika Robertson; Jason Sakamoto; Mauro Ferrari

doi:10.1016/j.mcna.2007.05.008

Biomedical Nanotechnology for Cancer

Amy Pope-Harman, Mark Ming Cheng Cheng, Fredika Robertson, Jason Sakamoto, Mauro Ferrari

Research output: Contribution to journal › Review article › peer-review

31 Scopus citations

Abstract

Nanotechnology may hold the key to controlling many devastating diseases. In the fight against the pain, suffering, and death due to cancer, nanotechnology will allow earlier diagnosis and even prevention of malignancy at premalignant stages, in addition to providing multimodality treatment not possible with current conventional techniques. This review discusses nanotechnology already used in diagnostic and therapeutic applications for cancer. Also addressed are theoretic and evolving uses of nanotechnology, including multifunctional nanoparticles for imaging and therapy, nanochannel implants for controlled release of drugs, nanoscale devices for evaluation of proteomics and genomics, and diagnostic techniques that take advantage of physical changes in diseased tissue.

Original language	English (US)
Pages (from-to)	899-927
Number of pages	29
Journal	Medical Clinics of North America
Volume	91
Issue number	5
DOIs	https://doi.org/10.1016/j.mcna.2007.05.008
State	Published - Sep 2007

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.mcna.2007.05.008

Cite this

@article{fdab114898ea44b897e9349c3c41e15c,

title = "Biomedical Nanotechnology for Cancer",

abstract = "Nanotechnology may hold the key to controlling many devastating diseases. In the fight against the pain, suffering, and death due to cancer, nanotechnology will allow earlier diagnosis and even prevention of malignancy at premalignant stages, in addition to providing multimodality treatment not possible with current conventional techniques. This review discusses nanotechnology already used in diagnostic and therapeutic applications for cancer. Also addressed are theoretic and evolving uses of nanotechnology, including multifunctional nanoparticles for imaging and therapy, nanochannel implants for controlled release of drugs, nanoscale devices for evaluation of proteomics and genomics, and diagnostic techniques that take advantage of physical changes in diseased tissue.",

author = "Amy Pope-Harman and Cheng, \{Mark Ming Cheng\} and Fredika Robertson and Jason Sakamoto and Mauro Ferrari",

note = "Funding Information: MCC and MF are grateful to the National Cancer Institute for funding under National Institutes of Health Contract No. NO1-CO-12400. ",

year = "2007",

month = sep,

doi = "10.1016/j.mcna.2007.05.008",

language = "English (US)",

volume = "91",

pages = "899--927",

journal = "Medical Clinics of North America",

issn = "0025-7125",

publisher = "W.B. Saunders",

number = "5",

}

TY - JOUR

T1 - Biomedical Nanotechnology for Cancer

AU - Pope-Harman, Amy

AU - Cheng, Mark Ming Cheng

AU - Robertson, Fredika

AU - Sakamoto, Jason

AU - Ferrari, Mauro

N1 - Funding Information: MCC and MF are grateful to the National Cancer Institute for funding under National Institutes of Health Contract No. NO1-CO-12400.

PY - 2007/9

Y1 - 2007/9

N2 - Nanotechnology may hold the key to controlling many devastating diseases. In the fight against the pain, suffering, and death due to cancer, nanotechnology will allow earlier diagnosis and even prevention of malignancy at premalignant stages, in addition to providing multimodality treatment not possible with current conventional techniques. This review discusses nanotechnology already used in diagnostic and therapeutic applications for cancer. Also addressed are theoretic and evolving uses of nanotechnology, including multifunctional nanoparticles for imaging and therapy, nanochannel implants for controlled release of drugs, nanoscale devices for evaluation of proteomics and genomics, and diagnostic techniques that take advantage of physical changes in diseased tissue.

AB - Nanotechnology may hold the key to controlling many devastating diseases. In the fight against the pain, suffering, and death due to cancer, nanotechnology will allow earlier diagnosis and even prevention of malignancy at premalignant stages, in addition to providing multimodality treatment not possible with current conventional techniques. This review discusses nanotechnology already used in diagnostic and therapeutic applications for cancer. Also addressed are theoretic and evolving uses of nanotechnology, including multifunctional nanoparticles for imaging and therapy, nanochannel implants for controlled release of drugs, nanoscale devices for evaluation of proteomics and genomics, and diagnostic techniques that take advantage of physical changes in diseased tissue.

UR - https://www.scopus.com/pages/publications/34548419696

UR - https://www.scopus.com/inward/citedby.url?scp=34548419696&partnerID=8YFLogxK

U2 - 10.1016/j.mcna.2007.05.008

DO - 10.1016/j.mcna.2007.05.008

M3 - Review article

C2 - 17826110

AN - SCOPUS:34548419696

SN - 0025-7125

VL - 91

SP - 899

EP - 927

JO - Medical Clinics of North America

JF - Medical Clinics of North America

IS - 5

ER -

Biomedical Nanotechnology for Cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this